Please login to the form below

Not currently logged in
Email:
Password:

IFPMA issues psoriasis call to action

Pharma industry body plans to raise awareness of disease
IFPMA logo

The International Federation of Pharmaceutical Manufacturers (IFPMA) has announced plans to develop awareness of psoriasis, a disease that affects 125 million people worldwide.

With its report 'Bringing Psoriasis Into the Light', the IFPMA is calling for action in three key areas: awareness, research and access.

To improve awareness, the IFPMA wants organisations to 'intensify and co-ordinate advocacy efforts to increase awareness of the public health impact of psoriasis'. It is calling for concerted efforts by public health organisations at all levels.

Emphasising the global nature of the problem while providing materials easily adaptable for local use is also key, said the IFPMA. It is also calling for better communication of the impact of psoriasis on economic activity, for example, in job markets or health and social policies.

The IFPMA is also calling for concerted new research across specialties; from molecular science to psychology and economics, to address 'the halo of impaired physical and psychological health surrounding psoriasis'.

More data is needed on the epidemiology and socioeconomic impact of the disease, the report concluded, in particular in non-Western societies and in under-researched groups such as children.

In addition, the IFPMA is pushing for greater research efforts into the impact on long-term cardiovascular risk from moderate and severe forms of psoriasis, and investment in a greater understanding of the psychosocial consequences of psoriasis for affected individuals and caregivers.

Global access to current effective therapies and to wider healthcare services such as counselling and self-care programmes must also be improved, found the IFPMA.

In addition to publishing the report, the IFPMA has welcomed the upcoming ministerial talks for the approval of a historic resolution on psoriasis at the 67th World Health Assembly, taking place in Geneva from 19 – 24 May.

Article by
Tara Craig

13th May 2014

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...